Laura Lovett

2 weeks ago | bhbusiness.com | Laura Lovett

The autism services industry is getting its groove back after some high-profile hiccups over the last few years. Specifically, investors have reupped interest in the space after a two-year lull. But as the industry comes into the limelight, providers continue to face significant challenges, including potential reductions in Medicaid funding and exchange-marketplace subsidies, while simultaneously working to develop emerging leaders from a workforce with less experience.

2 weeks ago | bhbusiness.com | Laura Lovett

Tad Health, a digital platform that helps mental health providers streamline administrative tasks, has raised $7.9 million in equity funding, according to public records. Founded in 2018, the software company provides billing, telehealth, referral and scheduling products, particularly for educational institutions. The startup has offerings for students, counselors and administrators.

2 weeks ago | bhbusiness.com | Laura Lovett

While private practice therapists continue to face significant reimbursement challenges from payers, as a whole, providers have increased their income over the last year. That’s according to Heard’s 2025 Financial State of Private Practice Report, which found that therapists earn significantly less from each session from insurance companies than from private pay. “Consistent with last year’s survey, insurance companies continue to under-reimburse therapists,” according to the report.

3 weeks ago | bhbusiness.com | Laura Lovett

This is an exclusive BHB+ storyWhile addressing the opioid crisis is often hailed as a bipartisan priority, the Trump administration’s sweeping reforms to mental health and substance use disorders (SUD) funding reveal a significant shift in America’s approach to these challenges. The new administration has focused its efforts on cracking down on illegal fentanyl and opioids entering the country. Meanwhile, it appears to be cutting back on funding and agencies involved in addressing the crisis.

3 weeks ago | bhbusiness.com | Laura Lovett

Digital therapeutics company Click Therapeutics has raised a whopping $48.5 million in funding, according to public documents. Click Therapeutics stands out as one of the few prominent digital therapeutics companies still actively securing investments following numerous high-profile market failures. Digital therapeutics refers to evidence-based treatments delivered through software interventions to treat or manage a condition.